Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pediatric Brain Tumor × Control Groups × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 35 Neoplasms 20 Motor Activity 10 Colorectal Neoplasms 9 Lung Neoplasms 7 Fatigue 7 Stomach Neoplasms 6 Pain, Postoperative 6 Anxiety Disorders 6 Pain 5 Depression 4 Colonic Neoplasms 4 Carcinoma, Hepatocellular 4 Thyroid Neoplasms 3 Stomatitis 3 Sleep Initiation and Maintenance Disorders 3 Polycystic Ovary Syndrome 3 Malnutrition 3 Leukemia, Myeloid, Acute 3 Agnosia 3 Vomiting 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Peritoneal Neoplasms 2 Parasomnias 2 Ovarian Neoplasms 2 Nausea 2 Lymphedema 2

Interventions

Carmustine 2 poly ICLC 1 dapagliflozin 1 Topotecan 1 High-Intensity Interval Training 1 Diet, Ketogenic 1 Cyclophosphamide 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05740839 2026-02-24

HYPE

Dana-Farber Cancer Institute

Phase NA Recruiting

Pediatric Brain Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡